Bloomberg Businessweek cover image

Lilly’s Zepbound Cut Risk of Diabetes by 94% in Obese People

Bloomberg Businessweek

Exploring Weight Loss Drugs and Their Long-Term Health Implications

3min Snip

00:00
Play full episode
This chapter explores the impacts of weight loss medications on health, focusing on type 2 diabetes and obesity-related conditions. It considers recent findings on their effectiveness, the implications of long-term use, and the interplay of economic factors and treatment combinations for optimal patient outcomes.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode